Category: Guest content

Tracking 20 Years of Compound-to-Target Output from Literature and Patents

This article was originally published by Christopher Southan, Peter Varkonyi, Kiran Boppana, Sarma A.R.P. Jagarlapudi, and Sorel Muresan at PLoS ONE 8(10): e77142. Abstract The statistics of drug development output and…
The post Tracking 20 Years…


Celgene vs. Dr. Reddy’s Revlimid patent infringement case depends on polymorph stability; lack thereof may favor Celgene position – experts

This article was originally published on November 30th 2017 by Hamish McDougall and Alaric DeArment of BioPharm Insight, part of GlobalData. Polymorph differences support noninfringement argument Trace solvate amount could destabalise…
The post C…


Making Medicines Affordable: A National Imperative

Consumer access to effective and affordable medicines is an imperative for public health, social equity, and economic development, but this need is not being served adequately by the biopharmaceutical sector,…
The post Making Medicines Affordable…


Patent Protection Strategies

This article was originally published by Himanshu Gupta, Suresh Kumar, Saroj Kumar Roy, and R. S. Gaud at J Pharm Bioallied Sci. 2010 Jan-Mar; 2(1): 2–7. Abstract It is widely recognized…
The post Patent Protection Strategies appeared first on Dr…


Leveraging affordable innovation to tackle India’s healthcare challenge

This article was originally published by Kiran Mazumdar Shaw in IIMB Management Review under a Creative Commons license. Abstract Affordable innovation, which presents ways to innovate, be flexible, and do more with…
The post Leveraging affordabl…


A Comparison of Generic Drug Prices in Seven European Countries: A Methodological Analysis

This paper was originally published by Olivier J. Wouters and Panos G. Kanavos in BMC Health Services Research  2017 17:242 https://doi.org/10.1186/s12913-017-2184-5 ©  The Author(s). 2017 Abstract Background Policymakers and researchers frequently com…


A Guide to Time Lag and Time Lag Shortening Strategies in Oncology-Based Drug Development

Transformation of a new scientific idea into a new oncology-based drug requires a tremendous amount of time, effort and investment. The initial, but critical first step in this process is transferring basic oncology research into a clinical application known as a “translational” or “bench to bedside study”. As a postdoctoral fellow who performs prostate cancer research related bench work, […]


Patenting the Microbiome – Part 2: Microbiome IP Panel, 2017 BIO Convention

This is a guest post from Susan K Finston, President of Finston Consulting. Do you have a response to Susan’s post? Respond in the comments section below.  Given the increasing focus on microbiome technologies for better, safer therapies, and critical importance of Intellectual Property (IP) protection for their full commercialization, it is great to see the 2017 […]


Solving the problem of biologic delivery: Large volume wearable injectors

This is a guest post from Michael D. Hooven, President & CEO, Enable Injections Inc. The oxpecker perches on the backs of zebras and eats the ticks and parasites that live on their skin. The bird gets its food, and the beasts get pest control. It’s an example of mutualism at its best – both parties […]


Do NOT follow this link or you will be banned from the site!
%d bloggers like this: